Scott Glaser(@DocGlaser) 's Twitter Profileg
Scott Glaser

@DocGlaser

Oncologist | Chief of #Brachytherapy and Gyn #radonc at
@cityofhope | Views are my own

ID:491312049

linkhttps://www.cityofhope.org/scott-glaser calendar_today13-02-2012 14:01:46

478 Tweets

2,2K Followers

3,1K Following

James Bates(@JamesBatesMD) 's Twitter Profile Photo

No longer at , but NRG Oncology major results with HN004 - cis-ineligible HNSCC randomized to RT + cetux vs RT + durva, concurrent immunotherapy with significantly increased LRF - concurrent immuno certainly does not appear to be the answer in definitive treatment

No longer at #ASTRO22, but @NRGonc major results with HN004 - cis-ineligible HNSCC randomized to RT + cetux vs RT + durva, concurrent immunotherapy with significantly increased LRF - concurrent immuno certainly does not appear to be the answer in definitive #hnscc treatment
account_circle
Scott Glaser(@DocGlaser) 's Twitter Profile Photo

Excellent presentation by City of Hope Radiation Oncology PGY-5, Dr. Elizabeth Germino! CD8 immunopet can be used to visualize the immune response generated by combination RT + anti-CTLA4.

Excellent presentation by @COH_RadOnc PGY-5, Dr. Elizabeth Germino! CD8 immunopet can be used to visualize the immune response generated by combination RT + anti-CTLA4.
account_circle
Scott Glaser(@DocGlaser) 's Twitter Profile Photo

CALLA presented at , no apparent benefit to concurrent and adjuvant IO. With this and OUTBACK being negative how can outcomes for high risk cervical cancer be improved?

CALLA presented at #astro22, no apparent benefit to concurrent and adjuvant IO. With this and OUTBACK being negative how can outcomes for high risk cervical cancer be improved?
account_circle